Advertisement
PRAX vs VERU
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRAX is a Buy and VERU is a Hold.
Momentum Indicator for PRAX turns positive, indicating new upward trend
PRAX saw its Momentum Indicator move above the 0 level on October 26, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 96 similar instances where the indicator turned positive. In 89 of the 96 cases, the stock moved higher in the following days. The odds of a move higher are at 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for PRAX just turned positive on October 20, 2026. Looking at past instances where PRAX's MACD turned positive, the stock continued to rise in 41 of 43 cases over the following month. The odds of a continued upward trend are 90%.
PRAX moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +21.60% 3-day Advance, the price is estimated to grow further. Considering data from situations where PRAX advanced for three days, in 257 of 301 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.
Bearish Trend Analysis
The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The 50-day moving average for PRAX moved below the 200-day moving average on October 22, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PRAX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
PRAX broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for PRAX entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 19 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.780) is normal, around the industry mean (3.498). P/E Ratio (-21.421) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (1000.000) is also within normal values, averaging (440.869).
The Tickeron PE Growth Rating for this company is 33 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. PRAX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 85 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PRAX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
VERU sees its Stochastic Oscillator recovers from oversold territory
On November 10, 2026, the Stochastic Oscillator for VERU moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 70 instances where the indicator left the oversold zone. In 61 of the 70 cases the stock moved higher in the following days. This puts the odds of a move higher at over 87%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where VERU's RSI Indicator exited the oversold zone, 20 of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 74%.
Following a +6.31% 3-day Advance, the price is estimated to grow further. Considering data from situations where VERU advanced for three days, in 205 of 248 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
VERU may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VERU as a result. In 88 of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for VERU turned negative on October 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In 38 of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
VERU moved below its 50-day moving average on October 06, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for VERU crossed bearishly below the 50-day moving average on October 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 18 of 20 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
The 50-day moving average for VERU moved below the 200-day moving average on October 26, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VERU declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
The Aroon Indicator for VERU entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 71 (best 1 - 100 worst), indicating slightly worse than average price growth. VERU’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.274) is normal, around the industry mean (3.498). P/E Ratio (-3.655) is within average values for comparable stocks, (-1.193). VERU's Projected Growth (PEG Ratio) (421.660) is very high in comparison to the industry average of (9.059). Dividend Yield (0.132) settles around the average of (130.981) among similar stocks. P/S Ratio (1.966) is also within normal values, averaging (440.869).
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VERU’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
PRAX | VERU | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 38 | 72 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 19 Undervalued | 98 Overvalued | |
PROFIT vs RISK RATING 1..100 | 85 | 100 | |
SMR RATING 1..100 | 97 | 98 | |
PRICE GROWTH RATING 1..100 | 38 | 71 | |
P/E GROWTH RATING 1..100 | 33 | 100 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
PRAX's Valuation (19) in the null industry is significantly better than the same rating for VERU (98) in the Household Or Personal Care industry. This means that PRAX’s stock grew significantly faster than VERU’s over the last 12 months.
PRAX's Profit vs Risk Rating (85) in the null industry is in the same range as VERU (100) in the Household Or Personal Care industry. This means that PRAX’s stock grew similarly to VERU’s over the last 12 months.
PRAX's SMR Rating (97) in the null industry is in the same range as VERU (98) in the Household Or Personal Care industry. This means that PRAX’s stock grew similarly to VERU’s over the last 12 months.
PRAX's Price Growth Rating (38) in the null industry is somewhat better than the same rating for VERU (71) in the Household Or Personal Care industry. This means that PRAX’s stock grew somewhat faster than VERU’s over the last 12 months.
PRAX's P/E Growth Rating (33) in the null industry is significantly better than the same rating for VERU (100) in the Household Or Personal Care industry. This means that PRAX’s stock grew significantly faster than VERU’s over the last 12 months.
| PRAX | VERU | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | 2 days ago 74% |
| Stochastic ODDS (%) | 2 days ago 79% | 2 days ago 87% |
| Momentum ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| MACD ODDS (%) | 2 days ago 90% | 3 days ago 90% |
| TrendWeek ODDS (%) | 2 days ago 87% | 2 days ago 90% |
| TrendMonth ODDS (%) | 2 days ago 89% | 2 days ago 88% |
| Advances ODDS (%) | 2 days ago 85% | 3 days ago 83% |
| Declines ODDS (%) | 10 days ago 83% | 10 days ago 89% |
| BollingerBands ODDS (%) | 2 days ago 82% | 2 days ago 84% |
| Aroon ODDS (%) | 2 days ago 86% | 2 days ago 85% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
PRAX’s FA Score shows that 2 FA rating(s) are green while VERU’s FA Score has 0 green FA rating(s).
- PRAX’s FA Score: 2 green, 3 red.
- VERU’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
PRAX’s TA Score shows that 4 TA indicator(s) are bullish while VERU’s TA Score has 4 bullish TA indicator(s).
- PRAX’s TA Score: 4 bullish, 6 bearish.
- VERU’s TA Score: 4 bullish, 7 bearish.
Price Growth
PRAX (@Biotechnology) experienced а +20.35% price change this week, while VERU (@Biotechnology) price change was -1.85% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was -2.72%, and the average quarterly price growth was -13.41%.
Reported Earning Dates
PRAX is expected to report earnings on Mar 03, 2027.
VERU is expected to report earnings on Dec 16, 2026.
Industries' Descriptions
@Biotechnology (+4.90% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
PRAX and
Correlation & Price change
A.I.dvisor indicates that over the last year, PRAX has been loosely correlated with FULC. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if PRAX jumps, then FULC could also see price increases.
| Ticker / NAME | Correlation To PRAX | 1D Price Change % | ||
|---|---|---|---|---|
| PRAX | 100% | +1.39% | ||
| FULC - PRAX | 45% Loosely correlated | N/A | ||
| IMVT - PRAX | 44% Loosely correlated | +1.59% | ||
| LXEO - PRAX | 43% Loosely correlated | -2.55% | ||
| CGEM - PRAX | 42% Loosely correlated | -4.26% | ||
| CELC - PRAX | 42% Loosely correlated | -4.72% | ||
More | ||||
VERU and
Correlation & Price change
A.I.dvisor indicates that over the last year, VERU has been loosely correlated with INDP. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if VERU jumps, then INDP could also see price increases.
| Ticker / NAME | Correlation To VERU | 1D Price Change % | ||
|---|---|---|---|---|
| VERU | 100% | -3.20% | ||
| INDP - VERU | 48% Loosely correlated | -7.35% | ||
| ABCL - VERU | 40% Loosely correlated | -0.32% | ||
| RXRX - VERU | 38% Loosely correlated | -6.70% | ||
| CRSP - VERU | 36% Loosely correlated | -9.77% | ||
| PRAX - VERU | 35% Loosely correlated | +1.39% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| KPHO | 22.20 | 0.39 | +1.79% |
| Kraneshares Dragon Capital Vietnam Growth Index ETF | |||
| SMIN | 70.85 | 0.28 | +0.40% |
| iShares MSCI India Small Cap ETF (SMIN) | |||
| WAMA | 26.34 | -0.10 | -0.38% |
| WisdomTree US Adaptive Moving Average Fund (WAMA) | |||
| GOOX | 47.62 | -0.27 | -0.56% |
| T-Rex 2X Long Alphabet Daily Target ETF (GOOX) | |||
| SPTI | 27.61 | -0.17 | -0.61% |
| State Street SPDR Portfolio Intermediate Term Treasury ETF (SPTI) | |||